# A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

> **NCT02615184** · PHASE2 · TERMINATED · sponsor: **Takeda** · enrollment: 24 (actual)

## Conditions studied

- Erosive Esophagitis

## Interventions

- **DRUG:** Dexlansoprazole

## Key facts

- **NCT ID:** NCT02615184
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-23
- **Primary completion:** 2026-04-13
- **Final completion:** 2026-04-13
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** Study related
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615184, "A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT02615184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
